Progestin effects on epidermal growth factor receptor (EGFR) endometrial expression in normal and hyperplastic endometrium.
Jasonni
V M
VM
Institute of Obstetrics and Gynecology, University of Modena and Reggio Emilia, Policlinico di Modena, 41100 Modena, Italy. jasonni.valeriomaria@unimore.it
La Marca
A
A
Santini
D
D
D000279:Administration, Cutaneous; D000284:Administration, Oral; D003613:Danazol / Q000627:therapeutic use; D004714:Endometrial Hyperplasia / Q000188:drug therapy / Q000378:metabolism*; D004717:Endometrium / Q000378:metabolism* / Q000473:pathology; D066246:ErbB Receptors / Q000378:metabolism*; D004958:Estradiol / Q000494:pharmacology*; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D011374:Progesterone / Q000494:pharmacology*
D004965:Estrogen Antagonists; D011374:Progesterone; D004958:Estradiol; D066246:ErbB Receptors; D003613:Danazol